Optic atrophies in metabolic disorders

Area of Science:

• Neuroscience
• Metabolic Disorders
• Ophthalmology

Background:

• Optic nerve damage in metabolic disorders stems from cellular apoptosis, affecting retinal ganglion cells (RGCs), oligodendrocytes, and vascular support.
• RGCs are highly sensitive to metabolic defects due to high energy demands and long axons.
• Clinical signs include pale optic nerves, indicating RGC axon loss.

Purpose of the Study:

• To review the mechanisms of optic atrophy in metabolic disorders.
• To highlight the significance of early optic atrophy identification for diagnosis and management.
• To emphasize the role of metabolic disorders in optic nerve pathology.

Main Methods:

• Review of existing literature on optic nerve involvement in metabolic diseases.
• Analysis of cellular mechanisms leading to optic atrophy.
• Discussion of diagnostic approaches including clinical examination, neuro-imaging, and family history.

Main Results:

• Metabolic defects disrupt energy metabolism, increase oxidative stress, and cause metabolite storage, leading to RGC apoptosis and oligodendrocyte dysfunction.
• Optic atrophy is a clinical manifestation of RGC axon loss.
• Diagnosis can be challenging, often requiring consideration of systemic metabolic disorders.

Conclusions:

• Optic atrophy is a significant indicator of underlying metabolic disorders.
• Early diagnosis facilitates timely management, genetic counseling, and potential therapeutic interventions.
• Molecular testing is available for many metabolic disorders, aiding diagnosis.